So I guess I don’t see that there is anything else to say re commercialisation LC has been saying since 2017 that they are aiming for ph2 - they did chemo + her vaxx. Now BP are interested with supply agreements they are doing ph 2 with keytruda etc for combo - these trials generally take 12-24 months so we won’t be in the space for a deal till then.
And re OV/ oncarlytics it seems they are going all the way - ref my post here https://hotcopper.com.au/threads/media-thread.5677706/page-6958?post_id=64316412.
I think there isn’t much else to clarify - it’s all there
Why IMU is a multi multi bagger, page-9528
-
- There are more pages in this discussion • 17,321 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $521.9K | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1612511 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 3882781 | 14 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |